SV Health Investors’ Ruth McKernan says wearables and health data are helping move medicine from the general to the personal. She says AI is already speeding up parts of drug discovery and improving patient selection for clinical trials. But McKernan says some parts of development cannot be rushed, and the UK still needs more funding to help life-sciences companies scale. She spoke to Tom Mackenzie on the latest episode of Bloomberg Tech: Europe. (Source: Bloomberg)
Business
1 views
AI is Accelerating Drug Discovery: McKernan
SV Health Investors’ Ruth McKernan says wearables and health data are helping move medicine from the general to the personal. She says AI is already speeding up parts of drug discovery.
Business
Bloomberg Verified Source
Syndicated via official news feed
Explore all Business stories
Syndicated feed content with full publisher credit.
Business Desk
More in Business
Continue reading verified coverage and related developments on this desk.